BOSTON SCIENTIFIC CORPORATION Revenues
BOSTON SCIENTIFIC CORPORATION (BSX) reported Revenues of $2.22 billion for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-02.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2017-11-02
- BOSTON SCIENTIFIC CORPORATION revenues for the quarter ending 2017-09-30 was $2.22B, a 5.73% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION revenues for the quarter ending 2017-06-30 was $2.28B, a 7.24% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION revenues for the quarter ending 2017-03-31 was $2.20B, a 10.16% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION revenues for the quarter ending 2016-12-31 was $2.85B, a 32.30% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION revenues for fiscal 2016 was $9.08B, a 12.49% increase from fiscal 2015.
- BOSTON SCIENTIFIC CORPORATION revenues for fiscal 2015 was $8.07B, a 8.12% increase from fiscal 2014.
- BOSTON SCIENTIFIC CORPORATION revenues for fiscal 2014 was $7.46B, a 5.51% increase from fiscal 2013.
- BOSTON SCIENTIFIC CORPORATION revenues for fiscal 2013 was $7.07B, a 1.64% increase from fiscal 2012.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month |
|---|---|---|---|---|---|---|---|
| 2017-09-30 | $2.22B 10-Q · filed 2017-11-02 | $4.50B derived: sum of 2 quarters · filed 2017-11-02 | $6.70B 10-Q · filed 2017-11-02 | $9.55B derived: sum of 4 quarters · filed 2017-11-02 | |||
| 2017-06-30 | $2.28B 10-Q · filed 2017-08-03 | $4.49B 10-Q · filed 2017-08-03 | $7.34B derived: sum of 3 quarters · filed 2017-08-03 | $9.43B derived: sum of 4 quarters · filed 2017-11-02 | |||
| 2017-03-31 | $2.20B 10-Q · filed 2017-05-03 | $5.06B derived: sum of 2 quarters · filed 2017-05-03 | $7.15B derived: sum of 3 quarters · filed 2017-11-02 | $9.28B derived: sum of 4 quarters · filed 2017-11-02 | |||
| 2016-12-31 | $2.85B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $4.95B derived: sum of 2 quarters · filed 2017-11-02 | $7.08B derived: sum of 3 quarters · filed 2017-11-02 | $9.08B 10-K · filed 2017-02-23 | |||
| 2016-09-30 | $2.10B 10-Q · filed 2017-11-02 | $2.25B 10-Q · filed 2016-11-03 | $4.22B derived: sum of 2 quarters · filed 2017-11-02 | $6.22B 10-Q · filed 2017-11-02 | $6.69B 10-Q · filed 2016-11-03 | $8.38B derived: sum of 4 quarters · filed 2017-11-02 | |
| 2016-06-30 | $2.13B 10-Q · filed 2017-08-03 | $2.29B 10-Q · filed 2016-08-03 | $4.13B 10-Q · filed 2017-08-03 | $4.43B 10-Q · filed 2016-08-03 | $6.28B derived: sum of 3 quarters · filed 2017-08-03 | $8.32B derived: sum of 4 quarters · filed 2017-08-03 | |
| 2016-03-31 | $2.00B 10-Q · filed 2017-05-03 | $4.16B derived: sum of 2 quarters · filed 2017-05-03 | $6.19B derived: sum of 3 quarters · filed 2017-05-03 | $8.18B derived: sum of 4 quarters · filed 2017-05-03 | |||
| 2015-12-31 | $2.16B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $4.20B derived: sum of 2 quarters · filed 2017-02-23 | $6.18B derived: sum of 3 quarters · filed 2017-02-23 | $8.07B 10-K · filed 2017-02-23 | |||
| 2015-09-30 | $2.04B 10-Q · filed 2016-11-03 | $4.02B derived: sum of 2 quarters · filed 2016-11-03 | $5.91B 10-Q · filed 2016-11-03 | $7.87B derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-06-30 | $1.98B 10-Q · filed 2016-08-03 | $3.87B 10-Q · filed 2016-08-03 | $5.83B derived: sum of 3 quarters · filed 2017-02-23 | $7.69B derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-03-31 | $1.89B 10-Q · filed 2015-05-06 | $3.85B derived: sum of 2 quarters · filed 2017-02-23 | $5.71B derived: sum of 3 quarters · filed 2017-02-23 | $7.58B derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | $1.96B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $3.81B derived: sum of 2 quarters · filed 2017-02-23 | $5.68B derived: sum of 3 quarters · filed 2017-02-23 | $7.46B 10-K · filed 2017-02-23 | |||
| 2014-09-30 | $1.86B 10-Q · filed 2015-11-04 | $3.73B derived: sum of 2 quarters · filed 2015-11-04 | $5.51B 10-Q · filed 2015-11-04 | $7.34B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-06-30 | $1.87B 10-Q · filed 2015-08-06 | $3.65B 10-Q · filed 2015-08-06 | $5.48B derived: sum of 3 quarters · filed 2016-02-24 | $7.22B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-03-31 | $1.78B 10-Q · filed 2015-05-06 | $3.61B derived: sum of 2 quarters · filed 2016-02-24 | $5.35B derived: sum of 3 quarters · filed 2016-02-24 | $7.14B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $1.83B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $3.57B derived: sum of 2 quarters · filed 2016-02-24 | $5.37B derived: sum of 3 quarters · filed 2016-02-24 | $7.07B 10-K · filed 2016-02-24 | |||
| 2013-09-30 | $1.74B 10-Q · filed 2014-11-05 | $3.53B derived: sum of 2 quarters · filed 2014-11-05 | $5.24B 10-Q · filed 2014-11-05 | ||||
| 2013-06-30 | $1.79B 10-Q · filed 2014-08-06 | $3.50B 10-Q · filed 2014-08-06 | |||||
| 2013-03-31 | $1.71B 10-Q · filed 2014-05-08 | ||||||
| 2012-12-31 | $6.96B 10-K · filed 2015-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |